Published in J Clin Psychiatry on April 01, 2012
Accelerated Theta Burst in Chronic Pain: A Biomarker Study | NCT03984201
The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry (2013) 1.29
Where in the brain is depression? Curr Psychiatry Rep (2012) 0.97
Auditory verbal hallucinations as atypical inner speech monitoring, and the potential of neurostimulation as a treatment option. Neurosci Biobehav Rev (2013) 0.91
Assessing brain plasticity across the lifespan with transcranial magnetic stimulation: why, how, and what is the ultimate goal? Front Neurosci (2013) 0.90
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul (2016) 0.88
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry (2016) 0.83
Transcranial magnetic stimulation for the treatment of major depression. Neuropsychiatr Dis Treat (2015) 0.80
Use of the Temperament and Character Inventory to Predict Response to Repetitive Transcranial Magnetic Stimulation for Major Depression. J Psychiatr Pract (2016) 0.77
Treatment-resistant Late-life Depression: Challenges and Perspectives. Curr Neuropharmacol (2015) 0.77
Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy. Depress Res Treat (2015) 0.76
Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study. J Psychiatry Neurosci (2016) 0.76
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics. Curr Neuropharmacol (2015) 0.76
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity. Neural Plast (2017) 0.75
Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic treatment outcomes for younger versus older patients. J Affect Disord (2017) 0.75
The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease. Front Hum Neurosci (2016) 0.75
A naturalistic, multi-site study of repetitive transcranial magnetic stimulation therapy for depression. J Affect Disord (2016) 0.75
Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis. Brain Stimul (2016) 0.75
Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry (2005) 5.72
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry (2005) 3.46
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry (2008) 1.89
Assessment of sleep in women with night eating syndrome. Sleep (2006) 1.56
The Night Eating Questionnaire (NEQ): psychometric properties of a measure of severity of the Night Eating Syndrome. Eat Behav (2007) 1.56
Unexpected reduction in migraine and psychogenic headaches following rTMS treatment for major depression: a report of two cases. CNS Spectr (2007) 1.52
Proposed diagnostic criteria for night eating syndrome. Int J Eat Disord (2010) 1.41
Electroconvulsive therapy after maxillofacial metallic implants. J ECT (2014) 1.38
Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep (2008) 1.22
Prevalence of the night eating syndrome in a psychiatric population. Am J Psychiatry (2006) 1.20
Circadian rhythm profiles in women with night eating syndrome. J Biol Rhythms (2009) 1.19
Neuroendocrine profiles associated with energy intake, sleep, and stress in the night eating syndrome. J Clin Endocrinol Metab (2005) 1.12
Night eating syndrome among nonobese persons. Int J Eat Disord (2004) 1.10
A descriptive study of non-obese persons with night eating syndrome and a weight-matched comparison group. Eat Behav (2008) 1.09
The night eating syndrome: a progress report. Appetite (2005) 1.08
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul (2010) 1.07
A paradigm for facilitating pharmacotherapy at a distance: sertraline treatment of the night eating syndrome. J Clin Psychiatry (2006) 0.97
Clinical manifestations, diagnosis, and empirical treatments for catatonia. Psychiatry (Edgmont) (2007) 0.96
Transcranial magnetic stimulation in the treatment of psychiatric disorders. Curr Psychiatry Rep (2009) 0.95
Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul (2012) 0.95
Development of criteria for a diagnosis: lessons from the night eating syndrome. Compr Psychiatry (2008) 0.94
Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J Clin Psychiatry (2011) 0.93
A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. J Affect Disord (2010) 0.92
Evaluation of diagnostic criteria for night eating syndrome using item response theory analysis. Eat Behav (2008) 0.89
Neonatal outcomes with the use of lamotrigine for bipolar disorder in pregnancy and breastfeeding: a case series and review of the literature. Psychopharmacol Bull (2009) 0.88
Cognitive behavior therapy for night eating syndrome: a pilot study. Am J Psychother (2010) 0.86
Vagus Nerve Stimulation (VNS) and Treatment of Depression: To the Brainstem and Beyond. Psychiatry (Edgmont) (2006) 0.84
Psychiatric consultation of patients with hyperemesis gravidarum. Arch Womens Ment Health (2009) 0.84
An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt) (2011) 0.82
Clinical approach to agitation after electroconvulsive therapy: a case report and literature review. J ECT (2002) 0.81
Pregnancy and depression: exploring a new potential treatment option. Curr Psychiatry Rep (2009) 0.81
Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study. J ECT (2012) 0.81
Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depress Anxiety (2007) 0.81
Cardiac complications of ECT: myocardial stunning syndrome and takotsubo cardiomyopathy after ECT: different names for the same phenomenon. J ECT (2010) 0.80
Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry. Psychiatry (Edgmont) (2006) 0.80
Functional neurosurgery in the treatment of severe obsessive compulsive disorder and major depression: overview of disease circuits and therapeutic targeting for the clinician. Psychiatry (Edgmont) (2008) 0.80
Electroconvulsive therapy in a 72-year-old woman with a history of Takotsubo cardiomyopathy: a case report and review of the literature. Brain Stimul (2009) 0.79
Transcranial magnetic stimulation maintenance as a substitute for maintenance electroconvulsive therapy: a case series. J ECT (2013) 0.78
Other therapeutic psychiatric uses of superficial brain stimulation. Handb Clin Neurol (2013) 0.78
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial. Psychopharmacol Bull (2008) 0.78
A case of delayed onset of threatened premature labor in association with electroconvulsive therapy in the third trimester of pregnancy. J ECT (2010) 0.78
T3 augmentation in major depressive disorder: safety considerations. Am J Psychiatry (2011) 0.77
Guidelines for the management of depression during pregnancy. Curr Psychiatry Rep (2010) 0.77
Use of the Temperament and Character Inventory to Predict Response to Repetitive Transcranial Magnetic Stimulation for Major Depression. J Psychiatr Pract (2016) 0.77
Transcranial magnetic stimulation in a 15-year-old patient with autism and comorbid depression. J ECT (2014) 0.77
Electroconvulsive therapy in a 96-year-old patient with severe aortic stenosis: a case report and review of the literature. J ECT (2008) 0.77
Transcranial magnetic stimulation: a device intended for the psychiatrist's office, but what is its future clinical role? Expert Rev Med Devices (2008) 0.76
Clinical characteristics and management of treatment-resistant depression. J Clin Psychiatry (2015) 0.76
Electroconvulsive therapy for treatment of major depression in a 100-year-old patient with severe aortic stenosis: a 5-year follow-up report. J ECT (2011) 0.75
Rethinking the treatment paradigm for bipolar depression: the importance of long-term management. CNS Spectr (2004) 0.75
Desipramine toxicity with terbinafine. Am J Psychiatry (2002) 0.75
Customized anesthetic preservation of ictal threshold in electroconvulsive therapy: role of adjunctive remifentanil with etomidate. J ECT (2005) 0.75
Editorial: the treatment of depression during pregnancy. Isr J Psychiatry Relat Sci (2011) 0.75
Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.75